Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Systemic fungal infections (Aspergillus species, Candida species, and/or Cryptococcus species infections) Age: Adult Condition: Liposomal amphotericin B |
Dose: Intravenous – Test dose 1 mg infused over 10 minutes, then 3 mg/kg Frequency: once daily Duration: At least 14 days Note: Infusion over 30-60 minutes. Maximum: 5 mg/kg daily. |
|
Indication: Cryptococcal Meningitis Age: Adult Condition: HIV-infected patients |
Dose: Intravenous – 6 mg/kg Frequency: every day |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Systemic Fungal Infections Condition: Test dose |
Dose: Intravenous – 0.1 mg/kg Note: not to exceed 1 mg; administer over 20-60 minutes |
|
Indication: Systemic Fungal Infections Condition: Initial dose |
Dose: Intravenous – 0.25 mg/kg/dose Frequency: once daily or every other day |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal Impairment, Creatinine Clearance less than 10 mL/minute |
Dose: Intravenous – 0.5-0.7 mg/kg Frequency: every 24-48 hours Note: Consider other antifungal agents that may be less nephrotoxic |
|
Condition: Intermittent hemodialysis |
Dose: Intravenous – 0.5-1 mg/kg Frequency: once daily after dialysis session |
Administration
- Hospital use only
- Given by IV infusion
Side Effect
- Anorexia
- Chills
- Diarrhea
- Fever
- Headache
- Hypokalemia
- Hypomagnesemia
- Hypotension
- Malaise
- Nausea
- Pain (generalized)
- Pain at injection site
- Renal function abnormalities
- Tachypnea
- Vomiting
- Arachnoiditis
- Delerium
- Flushing
- Hypertension
- Leukocytosis
- Lumbar nerve pain
- Paresthesia
- Urinary retention
- Agranulocytosis
- Anuria
- Bone marrow suppression
- Cardiac arrest
- Coagulation defects
- Convulsions
- Dyspnea
- Hearing loss
- Leukopenia
- Maculopapular rash
- Renal failure
- Thrombocytopenia
- Vision changes
- Anaphylactic reaction
- leucoencephalopathy
- Overdosage can result in cardio-respiratory arrest
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Flucytosine
|
Increased toxicity
|
|
Nephrotoxic medications
|
Enhanced drug induced renal toxicity
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Unopened vials of lyophilized material are to be stored at temperatures up to 25°C. The reconstituted product concentrate may be stored for up to 24 hours at 2-8° C.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.